We describe seven patients who developed malignancy before, after or at the onset of systemic lupus erythematosus (SLE). They comprise three cases of breast adenocarcinoma, two cases of Hodgkin's lymphoma, and one each of cholangiocarcinoma and thymoma. Only one of this group had been treated with cytotoxic agents, and five have subsequently died. They belonged to a group of 150 SLE patients, many of whom had been treated with steroids and cytotoxic agents, under long-term follow-up at a specialized lupus clinic. We discuss the reported association of malignancy in patients with SLE.
Green JA, Dawson AA, Walker W.Systemic lupus erythematosus and lymphoma. Lancet1987; ii: 753-6.
2.
Efremidis A. , Eiser AR, Grishman E., Rosenberg V.Hodgkin's lymphoma in an adolescent with systemic lupus erythematosus. Cancer1984; 53: 142-6.
3.
Buskila D., Gladman DD, Hannah W., Kahn HJPrimary malignant lymphoma of the spleen in systemic lupus erythematosus. J Rheumatol1989; 16: 993-6.
4.
Agudelo CA, Schumacher HR, Glick JH, Molina J.Non-Hodgkin's lymphoma in systemic lupus erythematosus: report of 4 cases with ultrastructural studies in 2. J Rheumatol1981; 8: 69-78.
5.
Pettersson T. , Pukkala E., Teppo L., Friman C.Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis1992; 51: 437-9.
6.
Butler RC, Thomas SM, Thompson JM, Keat ACAnaplastic myeloma in systemic lupus erythematosus. Ann Rheum Dis1984; 43: 653-5.
7.
Canoso JJ, Cohen ASMalignancy in a series of 70 patients with systemic lupus erythematosus . Arthritis Rheum1974; 17: 383-90.
Sulkes A., Naparstek Y.The infrequent association of systemic lupus erythematosus and solid tumours . Cancer1991; 68: 1389-93.
10.
Wallace DJ, Podell T., Weiner J. et al. Systemic lupus erythematosus: survival patterns. Experience with 609 patients. JAMA1981; 245: 764-9.
11.
Rosner S., Ginzler EM, Diamond HS et al. A multicenter study of outcome in systemic lupus erythematosus: II. Causes of death. Arthritis Rheum1982; 25: 612-7.
12.
Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271-7.
13.
Lewis RB, Castor CW, Knisley RE, Bole GGFrequency of neoplasia in, systemic lupus erythematosus and rheumatoid arthritis . Arthritis Rheum1976; 19: 1256-60.
14.
Black RA, Zilko PJ, Dawkins PL, Armstrong BK, Mastaglia GLCancer in connective tissue disease. Arthritis Rheum1982; 25: 1130-3.
15.
Wyburn-Mason R.SLE and lymphoma. Lancet1979; 1: 156.
Cudworth AG , Ellis A.Malignant lymphoma and acute SLE . Br Med J1972; III: 291-2.
18.
Nilsen BL, Missal ME, Condemi JJAppearance of Hodgkin's disease in a patient with systemic lupus erythematosus . Cancer1967; 20: 1930-3.
19.
Andrew VC, Zlatkov NBSystemic lupus erythematosus and neoplasia of the lymphoreticular system. J Dermatol1968; 80: 503-8.
20.
Goodwin JSRemission in systemic lupus erythematosus after combination chemotherapy for Hodgkin's disease. JAMA1980; 17: 1962.
21.
Houssiau FA , Kirkove C., Asherson RA, Hughes Grv, Timothy ARMalignant lymphoma systemic rheumatic diseases. A report of five cases. Clin Exp Rheum1991 ; 9: 515-8.
22.
Hench PK, Mayne JG, Kiely MJ, Dockerty MBClinical study of the rheumatic manifestations of lymphoma. Arthritis Rheum1962; 5: 301.
23.
Kassan SS, Thomas TL, Moutsopoulos H.M. et al. Increased risk of lymphoma in sicca syndrome. Arch Intern Med1978; 89: 888--92.
24.
Whaley K., Webb J., McAvoy B. et al. Sjögren's syndrome. 2: Clinical associations and immunological phenomena. Quart J Med1973; 66: 513-48.
25.
Worrall J., Snaith ML, Batchelor R., Lsenberg DASLE - a rheumatological view. Quart J Med1990; 275: 319-30.
26.
Elliot RW, Essenhigh DM, Morley ARCyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit. Br Med J1982 ; 284: 1160-1.
27.
Thrasher JB , Miller GJ, Wettlaufer JNBladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. J Urol1990; 143: 119-21.
28.
Nyberg G., Eriksson O., Westberg NGIncreased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy. Arthritis Rheum1981; 24: 648-50.
